← Douglas Elliman Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | $8.5m |
($46.4m)
-648.20%
|
$98.7m
+312.74%
|
($6.4m)
-106.49%
|
($43.2m)
-574.57%
|
($77.0m)
-78.39%
|
$14.3m
+118.58%
|
— | |
| Depreciation and amortization | $8.6m | $8.5m | $8.6m | $8.0m | $8.0m | $7.7m | $8.4m | $7.9m | |
| Deferred income taxes | $225k | $78k | ($73k) | $4.2m | ($15.4m) | $977k | $0 | $0 | |
| Non-cash stock-based compensation expense | — | $0 | $0 | $11.1m | $13.1m | $6.6m | $8.6m | — | |
| Impairment of fixed assets | $0 | $58.3m | $0 | $0 | $0 | $0 | $2.3m | — | |
| Receivables | ($2.3m) | ($4.8m) | ($11.7m) | $3.4m | ($2.2m) | $820k | ($3.9m) | $5.9m | |
| Income taxes receivables, net | — | — | $1.2m | ($7.7m) | $1.2m | $5.3m | $3.6m | — | |
| Accounts payable and accrued liabilities | $1.9m | $3.5m | ($1.1m) | ($22.7m) | $9.7m | ($6.9m) | $1.5m | ($1.4m) | |
| Accrued salary and benefits | ($1.6m) | ($1.3m) | $13.4m | ($7.2m) | ($5.3m) | ($4.6m) | $5.6m | — | |
| Other assets and liabilities | $1.2m | $3.3m | $20.2m | ($4.0m) | ($258k) | $2.9m | ($353k) | — | |
| Net cash used in operating activities | $7.6m |
$31.9m
+320.55%
|
$127.8m
+301.15%
|
($14.7m)
-111.53%
|
($30.4m)
-106.29%
|
($26.0m)
+14.64%
|
($13.9m)
+46.54%
|
($5.0m)
+64.23%
|
|
| Capital expenditures | ($8.1m) | ($6.1m) | ($4.1m) | ($8.5m) | ($6.1m) | ($5.5m) | ($3.4m) | ($4.8m) | |
| Equity in (earnings) losses from equity-method investments | ($8.5m) | $225k | $278k | $563k | $168k | ($36k) | ($187k) | — | |
| Purchase of debt securities | — | $0 | $0 | ($701k) | ($25k) | $0 | $0 | — | |
| Proceeds from sale or liquidation of long-term investments | — | — | $0 | $0 | $1.4m | $8.9m | $1.7m | — | |
| Purchase of long-term investments | $0 | $0 | ($365k) | ($1.1m) | ($190k) | ($330k) | ($138k) | — | |
| Proceeds from sale or liquidation of short-term investments | — | — | — | — | $0 | $0 | $97.7m | — | |
| Purchase of short-term investments | — | — | — | $0 | $0 | ($9.8m) | ($87.9m) | — | |
| Net cash provided by (used in) investing activities | ($1.5m) | ($4.1m) | ($8.9m) | ($12.7m) | ($5.2m) | ($6.8m) | $90.5m | $1.4m | |
| Change in fair value of the derivative embedded within convertible debt | — | — | — | $0 | $0 | $15.0m | $28.5m | — | |
| Proceeds from debt issuance | — | — | — | $0 | $0 | $48.8m | $0 | — | |
| Dividends on common stock | — | $0 | $0 | ($16.2m) | ($4.2m) | $0 | $0 | — | |
| Net cash (used in) provided by financing activities | ($19.1m) |
($143k)
+99.25%
|
$3.2m
+2334.97%
|
($30.0m)
-1038.77%
|
($6.2m)
+79.30%
|
$45.5m
+831.68%
|
($96.1m)
-311.42%
|
— | |
| Net (decrease) increase in cash, cash equivalents and restricted cash | ($13.1m) | $27.6m | $122.2m | ($57.5m) | ($41.9m) | $12.7m | ($19.5m) | — | |
| Cash, cash equivalents and restricted cash, beginning of year | $79.1m | $106.7m | $228.9m | $171.4m | $129.5m | $142.2m | $122.7m | — | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Loss on sale of assets | $0 | $1.2m | $186k | $11k | $37k | $205k | $204k | — | |
| Gain on disposal of business | — | — | — | — | $0 | $0 | ($81.7m) | — | |
| Net gains on investment securities | $0 | $0 | ($265k) | ($2.8m) | ($633k) | ($5.3m) | ($1.2m) | — | |
| Non-cash interest expense | — | — | — | $0 | $0 | $1.2m | $2.2m | — | |
| Non-cash lease expense | $18.0m | $17.3m | $18.7m | $20.6m | $22.4m | $20.6m | $19.2m | — | |
| Provision for credit losses | $0 | $1.5m | $3.3m | $4.1m | $4.7m | $5.2m | $4.4m | — | |
| Loss on extinguishment of liability | — | — | — | — | $0 | $0 | $466k | — | |
| Contract assets, net | — | — | — | ($12.2m) | $1.3m | ($6.0m) | ($7.5m) | — | |
| Operating right-of-use assets and operating lease liabilities, net | ($17.4m) | ($7.5m) | ($24.0m) | ($24.2m) | ($22.7m) | ($22.2m) | ($22.2m) | — | |
| Contract liabilities | — | — | — | $16.7m | ($516k) | $19.6m | $8.9m | — | |
| Antitrust litigation settlement | — | — | — | $0 | $0 | $10.0m | ($5.0m) | — | |
| Purchase of equity securities | $0 | $0 | ($4.0m) | ($2.1m) | ($300k) | $0 | $0 | — | |
| Purchase of investment securities at fair value | — | — | — | — | $0 | ($9.8m) | $0 | ($97.9m) | |
| Proceeds from disposal of business, less cash distributed | $0 | $2.8m | $0 | $0 | $0 | $0 | $82.5m | — | |
| Repayments of convertible note | — | — | — | — | $0 | $0 | ($94.1m) | — | |
| Deferred financing charges | — | — | — | $0 | $0 | ($2.0m) | $0 | — | |
| Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting | — | — | $0 | $0 | ($2.0m) | ($1.3m) | ($2.0m) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.